Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation
暂无分享,去创建一个
L. Liau | P. Mischel | I. Mellinghoff | Luke Peng | T. Chan | D. Solit | Andrew Kaufman | P. Paty | E. Vakiani | Z. Zeng | Kasthuri Kannan | L. Morris | I. Ganly | Deepa Ramaswami | L. Walsh | S. Eng | Bhuvanesh Singh | Ş. Turcan | Yongxing Gong | V. Banuchi | Y. Zou | Timothy Cloughesy | L. Morris | Y. Gong | L. Peng | T. Cloughesy | Şevin Turcan | T. Chan
[1] L. Goodrich,et al. Functional interactions between Fat family cadherins in tissue morphogenesis and planar polarity , 2012, Development.
[2] Hidemi Ito,et al. TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth , 2012, The Journal of experimental medicine.
[3] Hidemi Ito,et al. TGF-b synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth , 2012 .
[4] R. Gibbs,et al. Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1 , 2011, Science.
[5] A. McKenna,et al. The Mutational Landscape of Head and Neck Squamous Cell Carcinoma , 2011, Science.
[6] H. Grabsch,et al. Deletion of chromosome 4q predicts outcome in Stage II colon cancer patients , 2011, Cellular Oncology.
[7] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[8] M. A. Basson,et al. Characterization of a Dchs1 mutant mouse reveals requirements for Dchs1-Fat4 signaling during mammalian development , 2011, Development.
[9] G. Halder,et al. Hippo signaling: growth control and beyond , 2011, Development.
[10] Xiao Xu,et al. The xCELLigence system for real-time and label-free monitoring of cell viability. , 2011, Methods in molecular biology.
[11] Li Li,et al. Hippo signaling at a glance , 2010, Journal of Cell Science.
[12] Barry S Taylor,et al. Genomic and biological characterization of exon 4 KRAS mutations in human cancer. , 2010, Cancer research.
[13] Nader Sanai,et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma. , 2010, World neurosurgery.
[14] S. Croul,et al. The SFRP family of WNT inhibitors function as novel tumor suppressor genes epigenetically silenced in medulloblastoma , 2010, Oncogene.
[15] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[16] Derek Y. Chiang,et al. The landscape of somatic copy-number alteration across human cancers , 2010, Nature.
[17] S. Gabriel,et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.
[18] Barry Merriman,et al. U87MG Decoded: The Genomic Sequence of a Cytogenetically Aberrant Human Cancer Cell Line , 2010, PLoS genetics.
[19] Jianmin Zhang,et al. YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway , 2009, Nature Cell Biology.
[20] M. Takeichi,et al. Mammalian Fat and Dachsous cadherins regulate apical membrane organization in the embryonic cerebral cortex , 2009, The Journal of cell biology.
[21] C. Englert,et al. Scribble participates in Hippo signaling and is required for normal zebrafish pronephros development , 2009, Proceedings of the National Academy of Sciences.
[22] Diane M Simeone,et al. Oncogenic function of ATDC in pancreatic cancer through Wnt pathway activation and beta-catenin stabilization. , 2009, Cancer cell.
[23] Chao Qi,et al. Identification of Fat4 as a candidate tumor suppressor gene in breast cancers , 2009, International journal of cancer.
[24] V. Velebný,et al. The comparison of impedance-based method of cell proliferation monitoring with commonly used metabolic-based techniques. , 2009, Neuro endocrinology letters.
[25] H. Nagatsuka,et al. Frequent deletion of ING2 locus at 4q35.1 associates with advanced tumor stage in head and neck squamous cell carcinoma , 2009, Journal of Cancer Research and Clinical Oncology.
[26] Simone Brabletz,et al. E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer , 2009, Cancer and Metastasis Reviews.
[27] G. Parmigiani,et al. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.
[28] D. Busam,et al. An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.
[29] Joshua M. Korn,et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.
[30] Manfred Gessler,et al. Loss of Fat4 disrupts PCP signaling and oriented cell division and leads to cystic kidney disease , 2008, Nature Genetics.
[31] J. Inazawa,et al. Frequent silencing of a putative tumor suppressor gene melatonin receptor 1 A (MTNR1A) in oral squamous‐cell carcinoma , 2008, Cancer science.
[32] E. Lander,et al. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. , 2008, Cancer research.
[33] S. Baylin,et al. Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer , 2008, British Journal of Cancer.
[34] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[35] E. Lander,et al. Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma , 2007, Proceedings of the National Academy of Sciences.
[36] John E. Major,et al. Genomic mutation consequence calculator , 2007, Bioinform..
[37] Guy Cavet,et al. Comment on "The Consensus Coding Sequences of Human Breast and Colorectal Cancers" , 2007, Science.
[38] T. Miki,et al. Identification of homozygous deletions of tumor suppressor gene FAT in oral cancer using CGH-array , 2007, Oncogene.
[39] M. Toyota,et al. Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer , 2007, Oncogene.
[40] Rebecca A Betensky,et al. Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment. , 2007, Clinical cancer research : an official journal of the American Association for Cancer Research.
[41] Ratnesh K Singh,et al. Deletions in chromosome 4 differentially associated with the development of cervical cancer: evidence of slit2 as a candidate tumor suppressor gene , 2007, Human Genetics.
[42] Ken Chen,et al. PolyScan: an automatic indel and SNP detection approach to the analysis of human resequencing data. , 2007, Genome research.
[43] P. A. Futreal,et al. Loss of the Mismatch Repair Protein MSH6 in Human Glioblastomas Is Associated with Tumor Progression during Temozolomide Treatment , 2007, Clinical Cancer Research.
[44] Hans Clevers,et al. Wnt/β-Catenin Signaling in Development and Disease , 2006, Cell.
[45] G. Parmigiani,et al. The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.
[46] M. Katoh,et al. Comparative integromics on FAT1, FAT2, FAT3 and FAT4. , 2006, International journal of molecular medicine.
[47] M. Fraga,et al. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer , 2006, Oncogene.
[48] R. Cameron,et al. Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer. , 2006, Cancer research.
[49] N. Sibinga,et al. The Fat1 cadherin integrates vascular smooth muscle cell growth and migration signals , 2006, The Journal of cell biology.
[50] Tracy T Batchelor,et al. A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy. , 2006, Cancer research.
[51] S. Baylin,et al. Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? , 2006, Nature Reviews Cancer.
[52] 野島 正寛. Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer , 2006 .
[53] H. Clevers. Wnt/beta-catenin signaling in development and disease. , 2006, Cell.
[54] M. Gessler,et al. Expression of mouse dchs1, fjx1, and fat‐j suggests conservation of the planar cell polarity pathway identified in drosophila , 2005, Developmental dynamics : an official publication of the American Association of Anatomists.
[55] Jianbin Huang,et al. The Hippo Signaling Pathway Coordinately Regulates Cell Proliferation and Apoptosis by Inactivating Yorkie, the Drosophila Homolog of YAP , 2005, Cell.
[56] Kwonseop Kim,et al. Identification of MYCBP as a β-catenin/LEF-1 target using DNA microarray analysis , 2005 .
[57] M. Takeichi,et al. New insights into Fat cadherins , 2005, Journal of Cell Science.
[58] H. Clevers,et al. Wnt signalling in stem cells and cancer , 2005, Nature.
[59] Kwonseop Kim,et al. Identification of MYCBP as a beta-catenin/LEF-1 target using DNA microarray analysis. , 2005, Life sciences.
[60] S. Aaronson,et al. An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. , 2004, Cancer cell.
[61] G. Saldanha,et al. Nuclear β‐catenin in basal cell carcinoma correlates with increased proliferation , 2004, The British journal of dermatology.
[62] S. Baumgartner,et al. The fat-like Gene of Drosophila Is the True Orthologue of Vertebrate Fat Cadherins and Is Involved in the Formation of Tubular Organs* , 2004, Journal of Biological Chemistry.
[63] M. Takeichi,et al. Mammalian Fat1 cadherin regulates actin dynamics and cell–cell contact , 2004, The Journal of cell biology.
[64] Wei Dong Chen,et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer , 2004, Nature Genetics.
[65] Yvonne Wallis,et al. The Wnt Antagonist sFRP1 in Colorectal Tumorigenesis , 2004, Cancer Research.
[66] Douglas A. Hosack,et al. Identifying biological themes within lists of genes with EASE , 2003, Genome Biology.
[67] B. Gumbiner,et al. Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin , 2003, The Journal of cell biology.
[68] Carmen Birchmeier,et al. beta-Catenin signals regulate cell growth and the balance between progenitor cell expansion and differentiation in the nervous system. , 2003, Developmental biology.
[69] C. ffrench-Constant,et al. Mice Lacking the Giant Protocadherin mFAT1 Exhibit Renal Slit Junction Abnormalities and a Partially Penetrant Cyclopia and Anophthalmia Phenotype , 2003, Molecular and Cellular Biology.
[70] J. Behrens,et al. The Wnt signaling pathway and its role in tumor development , 2003, Journal of Cancer Research and Clinical Oncology.
[71] Susan Summers,et al. Regulation of endothelial barrier function and growth by VE-cadherin, plakoglobin, and beta-catenin. , 2002, American journal of physiology. Cell physiology.
[72] K. Kinzler,et al. Targeted inactivation of CTNNB1 reveals unexpected effects of β-catenin mutation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[73] Kathleen R. Cho,et al. ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation. , 2002, Cancer cell.
[74] K. Kinzler,et al. Targeted inactivation of CTNNB1 reveals unexpected effects of beta-catenin mutation. , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[75] Wayne A. Phillips,et al. Id2 Is a Target of the β-Catenin/T Cell Factor Pathway in Colon Carcinoma* , 2001, The Journal of Biological Chemistry.
[76] K. Aldape,et al. Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. , 2001, Cancer research.
[77] B. Gumbiner,et al. E-Cadherin Suppresses Cellular Transformation by Inhibiting β-Catenin Signaling in an Adhesion-Independent Manner , 2001, The Journal of cell biology.
[78] B. Geiger,et al. Cadherin sequences that inhibit beta-catenin signaling: a study in yeast and mammalian cells. , 2001, Molecular biology of the cell.
[79] S. Rockman,et al. Id2 is a target of the beta-catenin/T cell factor pathway in colon carcinoma. , 2001, The Journal of biological chemistry.
[80] N. Niikawa,et al. Involvement of claudin-1 in the beta-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers. , 2001, Oncology research.
[81] Elizabeth M. Smigielski,et al. dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..
[82] David I. Smith,et al. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating β-catenin/TCF signalling , 2000, Nature Genetics.
[83] David I. Smith,et al. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling (vol 26, pg 146, 2000) , 2000 .
[84] S. Orsulic,et al. E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation. , 1999, Journal of cell science.
[85] B. Geiger,et al. Inhibition of β-catenin-mediated transactivation by cadherin derivatives , 1998 .
[86] Kenneth M. Yamada,et al. Modulation of cell-cell adherens junctions by surface clustering of the N-cadherin cytoplasmic tail. , 1998, Experimental cell research.
[87] A. Sparks,et al. Identification of c-MYC as a target of the APC pathway. , 1998, Science.
[88] Benjamin Geiger,et al. Differential Nuclear Translocation and Transactivation Potential of β-Catenin and Plakoglobin , 1998, The Journal of cell biology.
[89] P. Green,et al. Consed: a graphical tool for sequence finishing. , 1998, Genome research.
[90] B. Geiger,et al. Inhibition of beta-catenin-mediated transactivation by cadherin derivatives. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[91] W F Bodmer,et al. Beta-catenin mutations in cell lines established from human colorectal cancers. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[92] D. Nickerson,et al. PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. , 1997, Nucleic acids research.
[93] K. Kinzler,et al. Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma , 1997, Science.
[94] Hans Clevers,et al. Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.
[95] Michael Kühl,et al. Functional interaction of β-catenin with the transcription factor LEF-1 , 1996, Nature.
[96] Hans Clevers,et al. XTcf-3 Transcription Factor Mediates β-Catenin-Induced Axis Formation in Xenopus Embryos , 1996, Cell.
[97] H. Höfler,et al. No Evidence for Mutations in the α- and β-Catenin Genes in Human Gastric and Breast Carcinomas , 1996 .
[98] H. Höfler,et al. No evidence for mutations in the alpha- and beta-catenin genes in human gastric and breast carcinomas. , 1996, Cancer research.
[99] R Grosschedl,et al. Functional interaction of beta-catenin with the transcription factor LEF-1. , 1996, Nature.
[100] R. Poulsom,et al. Molecular cloning and tissue expression of FAT, the human homologue of the Drosophila fat gene that is located on chromosome 4q34-q35 and encodes a putative adhesion molecule. , 1995, Genomics.
[101] M. Takeichi. Morphogenetic roles of classic cadherins. , 1995, Current opinion in cell biology.
[102] S Ichii,et al. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. , 1992, Human molecular genetics.
[103] Peter J. Bryant,et al. The fat tumor suppressor gene in Drosophila encodes a novel member of the cadherin gene superfamily , 1991, Cell.
[104] M. Baer,et al. Structure and transcription of a human gene for H1 RNA, the RNA component of human RNase P , 1990, Nucleic Acids Res..
[105] P J Bryant,et al. Mutations at the fat locus interfere with cell proliferation control and epithelial morphogenesis in Drosophila. , 1988, Developmental biology.
[106] S. Orsulic,et al. E-cadherin binding prevents β-catenin nuclear localization and β-catenin / LEF-1-mediated transactivation , 2022 .